Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Privia Health Group, Inc. - Common Stock (NQ:PRVA)

23.04 +1.23 (+5.64%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Privia Health Group, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Why Is Privia Health (PRVA) Stock Soaring Today
Shares of healthcare tech company Privia Health Group (NASDAQ:PRVA) jumped 6.4% in the morning session after the company announced its Accountable Care Organizations (ACOs) achieved $233.1 million in... 
Via StockStory
Topics Initial Public Offering Lawsuit
Q2 Earnings Highlights: Omnicell (NASDAQ:OMCL) Vs The Rest Of The Healthcare Technology for Providers Stocks
Looking back on healthcare technology for providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Omnicell (NASDAQ:OMCL) and its peers. 
Via StockStory
3 Cash-Producing Stocks We Think Twice About
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
Healthcare Technology Stocks Q2 Highlights: Hims & Hers Health (NYSE:HIMS)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at healthcare technology stocks, starting... 
Via StockStory
Earnings Scheduled For August 7, 2025
 
Via Benzinga
Earnings Scheduled For May 8, 2025
 
Via Benzinga
PRVA Q2 Deep Dive: Platform Growth, Provider Expansion, and Margin Stability Drive Outperformance
Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 23.4% year on year to $521.2 million. The company expects... 
Via StockStory
Beyond The Numbers: 4 Analysts Discuss Privia Health Gr Stock
 
Via Benzinga
Privia Health (NASDAQ:PRVA) Reports Upbeat Q2
Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 23.4% year on year to $521.2 million. The company expects... 
Via StockStory
Privia Health Group Inc (NASDAQ:PRVA) Reports Mixed Q2 2025 Results, Raises Full-Year Guidance Despite Earnings Miss
Privia Health (PRVA) reported mixed Q2 2025 results, missing revenue and EPS estimates but raising full-year guidance, sparking a 6.2% pre-market stock surge. 
Via Chartmill
Privia Health (PRVA) Reports Q2: Everything You Need To Know Ahead Of Earnings
Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be reporting results this Thursday before the bell. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence Government World Trade
3 Healthcare Stocks That Concern Us
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
Why Privia Health (PRVA) Stock Is Up Today
Shares of healthcare tech company Privia Health Group (NASDAQ:PRVA) jumped 3.4% in the morning session as investors anticipated a heavy week of corporate earnings. There was no company-specific news to... 
Via StockStory
Topics Initial Public Offering Lawsuit Stocks
Enovis, CONMED, Astrana Health, Privia Health, and Waters Corporation Stocks Trade Down, What You Need To Know
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit World Trade
1 Profitable Stock with Competitive Advantages and 2 to Turn Down
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
1 Stock Under $50 with Competitive Advantages and 2 to Steer Clear Of
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
Topics Retirement
2 Cash-Heavy Stocks with Exciting Potential and 1 to Steer Clear Of
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining... 
Via StockStory
3 Small-Cap Stocks in Hot Water
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
PRVA Q1 Earnings Call: Arizona Expansion and Value-Based Care Execution Offset Revenue Miss
Healthcare tech company Privia Health Group (NASDAQ:PRVA) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 15.6% year on year to $480.1 million. Its non-GAAP EPS of $0.22 per... 
Via StockStory
1 of Wall Street’s Favorite Stock on Our Watchlist and 2 to Think Twice About
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
11 Analysts Have This To Say About Privia Health Gr
 
Via Benzinga
3 Healthcare Stocks with Mounting Challenges
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
Via StockStory
Topics Stocks
Unpacking Q1 Earnings: Privia Health (NASDAQ:PRVA) In The Context Of Other Healthcare Technology for Providers Stocks
Looking back on healthcare technology for providers stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Privia Health (NASDAQ:PRVA) and its peers. 
Via StockStory
3 Dawdling Stocks with Mounting Challenges
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
Topics Supply Chain
Privia Health (NASDAQ:PRVA) Exceeds Q1 Expectations
Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 15.6% year on year to $480.1 million. On the other hand,... 
Via StockStory
Privia Health (PRVA) Reports Earnings Tomorrow: What To Expect
Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be reporting results tomorrow before the bell. Here’s what to look for. 
Via StockStory
3 Stocks Under $50 That Concern Us
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some... 
Via StockStory
Q4 Earnings Highs And Lows: Premier (NASDAQ:PINC) Vs The Rest Of The Healthcare Technology for Providers Stocks
Looking back on healthcare technology for providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Premier (NASDAQ:PINC) and its peers. 
Via StockStory
Topics Economy
Investigating Privia Health Gr's Standing In Health Care Providers &amp; Services Industry Compared To Competitors
 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.